Zhende Medical’s First Extraordinary Meeting Signals Bold Growth Amid High‑PE Stakes
Zhende Medical’s first extraordinary general meeting reveals its high‑growth vision, a 66‑P/E valuation and global wound‑care strategy that investors and healthcare professionals closely monitor for future upside.
3 minutes to read

